HAILIFE

Name

HAILIFE

Legal name

深圳市和来生物技术有限公司

Website

https://hailife.com.cn

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD) - Blood Cell Analyzers

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

Keywords

• In vitro diagnostics
• Blood cell analyzers
• Point-of-care testing
• Medical device manufacturing
• Diagnostic reagents

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. IVD Instruments and Reagents: Sale of desktop and portable blood analyzers along with supporting diagnostic reagents for clinical testing applications

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

HAILIFE develops, manufactures, and sells low-cost, high-performance desktop and portable blood analyzers together with supporting diagnostic reagents for in vitro diagnostic (IVD) testing. The platforms enable blood cell counting, white blood cell three-part classification, hemoglobin concentration measurement, and specific protein concentration determination for primary healthcare settings.

Product overview

Hailife (深圳市和来生物技术有限公司) is a high-tech enterprise established in May 2020, focused on developing low-cost, high-performance desktop multi-functional in vitro diagnostic testing platforms. The product portfolio consists of three core offerings: the Desktop Blood Analyzer (台式血液分析仪) and Portable Blood Analyzer (便携血液分析仪) as the primary instrument platforms, along with supporting Testing Reagents (检测试剂) as consumables. The company emphasizes clinical needs as its guiding principle, aiming to make diagnostic testing more accessible through affordable, high-performance solutions. The company has obtained national high-tech enterprise certification and maintains a team where over 90% of employees hold bachelor's degrees or above.

Differentiator

Problem solved

Functional benefit

Products and services

• 台式血液分析仪 (Desktop Blood Analyzer) A desktop-style blood analyzer for clinical laboratory use, capable of blood cell counting, white blood cell three-part classification, hemoglobin concentration measurement, and specific protein concentration detection. Targeted at clinics, community health stations, and township health centers.
• 便携血液分析仪 (Portable Blood Analyzer) A portable blood analyzer designed for point-of-care testing, offering similar functionality to the desktop version (blood cell counting, white blood cell three-part classification, hemoglobin, specific protein) in a mobile form factor for use in various clinical settings.
• 检测试剂 (Testing Reagents) Supporting reagent consumables designed for use with HAILIFE's blood analyzer instruments, enabling various diagnostic tests including blood cell analysis and specific protein detection.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Sinocare Inc. Sinocare is a leading Chinese POCT diagnostics company most known for blood-glucose meters and a growing IVD/reagent portfolio. Its focus on affordable instruments for community and primary-care channels mirrors Hailife's positioning.
• Improve Medical Instruments: Improve Medical (普门科技) is a Shenzhen-based Chinese IVD company producing clinical analyzers and reagents including hematology instruments. It is closely comparable to Hailife in product scope and geographic focus.
• Dirui Industrial Co., Ltd. Dirui manufactures clinical chemistry, urine and hematology analyzers along with IVD reagents in China. Its desktop hematology and reagent consumables overlap closely with Hailife's product line.
• Wondfo Biotech: Wondfo Biotech is one of China's largest POCT/IVD companies and is also a disclosed investor in Hailife. It competes directly in the affordable POCT-blood-analyser and reagent segment for primary-care settings that Hailife targets.

Broad incumbents

• Sysmex Corporation: Sysmex is the global leader in hematology analyzers and reagents. Its CBC and 3-part/5-part diff systems define the performance bar that Hailife's HL-A550/HL-A530 must compete against in primary-care settings globally.
• Beckman Coulter (Danaher): Beckman Coulter is a global hematology/IVD incumbent with established installed bases. It is a comparable competitor to Hailife at the small-lab hematology tier worldwide.
• Autobio Diagnostics Co., Ltd. Autobio is a leading Chinese IVD company with immunoassay, microbiology and clinical-chemistry platforms plus reagents. While larger and broader than Hailife, it competes in the same Chinese hospital/clinic reagent ecosystem.
• Maccura Biotechnology Co., Ltd. Maccura is a major Chinese IVD manufacturer offering clinical chemistry, immunoassay and hematology analyzers plus reagents. Its product breadth overlaps Hailife's offerings, though it serves larger hospital labs as well.
• Mindray Bio-Medical Electronics: Mindray is a large Chinese medical-device incumbent with a broad IVD portfolio including hematology analyzers. It competes with Hailife across all tiers but is not focused on the low-cost primary-care niche.
• HORIBA Medical: HORIBA Medical produces compact hematology analyzers and reagents for small-to-mid labs, including emerging markets. It is a global incumbent comparable to Hailife on form factor and customer segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HAILIFE